Literature DB >> 35084686

Three-dimensional echocardiography for predicting mitral stenosis after MitraClip for functional mitral regurgitation.

Yuta Kato1, Atsushi Okada2, Makoto Amaki1, Kunihiro Nishimura3, Hideaki Kanzaki1, Yu Kataoka1, Koji Miyamoto1, Yasuhiro Hamatani1, Masashi Amano1, Hiroyuki Takahama1, Takuya Hasegawa1, Kengo Kusano1, Tomoyuki Fujita4, Junjiro Kobayashi4, Satoshi Yasuda1, Chisato Izumi1.   

Abstract

BACKGROUND: Postprocedural mitral stenosis (MS), or increased transmitral mean pressure gradient (TMPG), is one of the limitations of transcatheter edge-to-edge mitral valve repair using MitraClip (Abbott Vascular Inc., Santa Clara, USA); however, the usefulness of three-dimensional transesophageal echocardiography (3D-TEE) for predicting postprocedural MS in functional mitral regurgitation (MR) has not been fully elucidated.
METHODS: Eighty-two consecutive functional MR patients who underwent transcatheter mitral valve repair using MitraClip were retrospectively studied. Postprocedural MS was defined as TMPG ≥ 5 mmHg by echocardiography.
RESULTS: Ten patients had postprocedural MS, and 3D-TEE showed that patients with postprocedural MS had smaller preprocedural mitral valve orifice area (MVOA), anteroposterior and mediolateral diameter, leaflet area, and annulus area. Receiver operating characteristic analysis showed that leaflet area (area under the curve (AUC) 0.829), annulus area (AUC 0.813), anteroposterior diameter (AUC 0.797) and mediolateral diameter (AUC 0.803) evaluated using 3D-TEE were predictors of postprocedural MS, and their predictive abilities were higher than those of preprocedural MVOA (AUC 0.756) and preprocedural TMPG (AUC 0.716). Adding leaflet area to TMPG and MVOA resulted in higher C-statistics for predicting postprocedural MS (from 0.716 to 0.845 and from 0.756 to 0.853, respectively).
CONCLUSIONS: In functional MR patients treated with MitraClip, leaflet area and annulus area evaluated using 3D-TEE had high predictive values for postprocedural MS, and their predictive abilities were higher than those of preprocedural TMPG or MVOA.
© 2022. Japanese Society of Echocardiography.

Entities:  

Keywords:  3-dimensional transesophageal echocardiography (3D-TEE); Atrial functional mitral regurgitation; MitraClip; Mitral stenosis; Predictor; Ventricular functional mitral regurgitation

Mesh:

Year:  2022        PMID: 35084686     DOI: 10.1007/s12574-022-00564-x

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  48 in total

1.  Quantification of mitral valve anatomy by three-dimensional transesophageal echocardiography in mitral valve prolapse predicts surgical anatomy and the complexity of mitral valve repair.

Authors:  Patric Biaggi; Sean Jedrzkiewicz; Christiane Gruner; Massimiliano Meineri; Jacek Karski; Annette Vegas; Felix C Tanner; Harry Rakowski; Joan Ivanov; Tirone E David; Anna Woo
Journal:  J Am Soc Echocardiogr       Date:  2012-04-24       Impact factor: 5.251

2.  MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome.

Authors:  Edith Lubos; Michael Schlüter; Eik Vettorazzi; Britta Goldmann; Daniel Lubs; Johannes Schirmer; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Stephan Baldus; Volker Rudolph
Journal:  JACC Cardiovasc Interv       Date:  2014-03-14       Impact factor: 11.195

3.  Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.

Authors:  Michael Neuss; Thomas Schau; Akihiro Isotani; Markus Pilz; Maren Schöpp; Christian Butter
Journal:  JACC Cardiovasc Interv       Date:  2017-05-08       Impact factor: 11.195

4.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Stephan Baldus; Wolfgang Schillinger; Olaf Franzen; Raffi Bekeredjian; Horst Sievert; Joachim Schofer; Karl-Heinz Kuck; Thomas Konorza; Helge Möllmann; Christoph Hehrlein; Taoufik Ouarrak; Jochen Senges; Thomas Meinertz
Journal:  Eur J Heart Fail       Date:  2012-06-08       Impact factor: 15.534

5.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.

Authors:  Francesco Maisano; Olaf Franzen; Stephan Baldus; Ulrich Schäfer; Jörg Hausleiter; Christian Butter; Gian Paolo Ussia; Horst Sievert; Gert Richardt; Julian D Widder; Tiziano Moccetti; Wolfgang Schillinger
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

6.  AVJ-514 Trial - Baseline Characteristics and 30-Day Outcomes Following MitraClip® Treatment in a Japanese Cohort.

Authors:  Kentaro Hayashida; Satoshi Yasuda; Takashi Matsumoto; Makoto Amaki; Shingo Mizuno; Tetsuya Tobaru; Kentaro Jujo; Tatsushi Ootomo; Junichi Yamaguchi; Keiichi Fukuda; Shigeru Saito; Elyse Foster; Atif Qasim; Masafumi Kitakaze; Ryohei Yozu; Morimasa Takayama
Journal:  Circ J       Date:  2017-03-17       Impact factor: 2.993

7.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

8.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.

Authors:  Jean-François Obadia; David Messika-Zeitoun; Guillaume Leurent; Bernard Iung; Guillaume Bonnet; Nicolas Piriou; Thierry Lefèvre; Christophe Piot; Frédéric Rouleau; Didier Carrié; Mohammed Nejjari; Patrick Ohlmann; Florence Leclercq; Christophe Saint Etienne; Emmanuel Teiger; Lionel Leroux; Nicole Karam; Nicolas Michel; Martine Gilard; Erwan Donal; Jean-Noël Trochu; Bertrand Cormier; Xavier Armoiry; Florent Boutitie; Delphine Maucort-Boulch; Cécile Barnel; Géraldine Samson; Patrice Guerin; Alec Vahanian; Nathan Mewton
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

9.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Authors:  Gregg W Stone; JoAnn Lindenfeld; William T Abraham; Saibal Kar; D Scott Lim; Jacob M Mishell; Brian Whisenant; Paul A Grayburn; Michael Rinaldi; Samir R Kapadia; Vivek Rajagopal; Ian J Sarembock; Andreas Brieke; Steven O Marx; David J Cohen; Neil J Weissman; Michael J Mack
Journal:  N Engl J Med       Date:  2018-09-23       Impact factor: 91.245

10.  Successful Treatment of Mitral Regurgitation after Transapical Transcatheter Aortic Valve Implantation by Percutaneous Edge-to-edge Mitral Valve Repair (MitraClip®) -The First Combination Therapy Performed in Japan.

Authors:  Atsushi Okada; Hideaki Kanzaki; Makoto Amaki; Yu Kataoka; Koji Miyamoto; Yasuhiro Hamatani; Masashi Fujino; Hiroyuki Takahama; Takuya Hasegawa; Yusuke Shimahara; Yoshiaki Morita; Yasuo Sugano; Kengo Kusano; Yoshihiko Ohnishi; Tomoyuki Fujita; Junjiro Kobayashi; Toshihisa Anzai; Satoshi Yasuda
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.